2 stage PK study in 3 prototype buprenorphine patches

• Research type

  Research Study

• Full title

  A stage 2, randomised, open-label, crossover design pharmacokinetic study of relative and absolute bioavailability and dose proportionality in 3 prototype Buprenorphine Transdermal Deliver System second generation patches.

• IRAS ID

  82833

• Contact name

  David J A Bell

• Contact email

  david@biokineticeurope.com

• Sponsor organisation

  Mundipharma Research Ltd

• Eudract number

  2011-000974-69

• Research summary

  Research Summary not published at request of researcher

• REC name

  HSC REC A

• REC reference

  11/NI/0103

• Date of REC Opinion

  8 Aug 2011

• REC opinion

  Further Information Favourable Opinion